The applicant is frequently called upon to tackle administrative tasks and demonstrate leadership both within the academic world and in industry. By serving a broad assortment of organizations, I have gained new insights into the importance of sharing my leadership and shaping the future of education and focusing the research of pharmaceutical industries. Most recently, I was honored to be designated as Director of the Swedish National Biological Mass Spectrometry Infrastructure (BioMS) by the LU Provost for Research, Dr. Stacey Sörenson. As Director, I am the leader for BioMS research units in Lund, Goteborg (Goteborg University and Chalmers Institute of Technology), and Stockholm (Karolinska Institutet). In essence, the position encompasses Chief Executive Officer, Chief Operating Officer, and Chief Financial Officer for the BioMS consortium. Earlier (October 2015), I was elected Director of CEBMMS. CEBMMS is a research arena comprised of eight P.I.’s and approximately sixty students, post-docs, and scientists. I have Director Emeritus status currently, following the acceptance of the directorship for BioMS.…show more content… For example, while at Pfizer, the scientific leaders in my research area met regularly to discuss leadership issues with each other. We discussed openly each others strengths. My colleagues identified my personal strengths as trustworthiness, empathy, responsibility, strategic thinker, and engagement in learning. Honesty, integrity and trustworthiness are important facets of the essential keys to good leadership. A leader must be consistent and clear in communications in order to keep the respect of every group